Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

Hims & Hers (NYSE:HIMS) stock slips as U.S. lawmakers seek FDA action against copycat versions of weight loss drugs from Novo ...

The age-old advice to lose weight is to exercise and eat healthy, but what if you can’t work out regularly (or just don’t ...

Tears Pour In for Sheryl Swoopes After Sharing Life-Changing Event originally appeared on Athlon Sports. WNBA legend Sheryl ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to ...

The new novel, out July 29 from Flatiron Books, follows a group of mothers whose children are enrolled at the ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

The researchers first tested their hypothesis by delivering ODN directly to the hindbrain of rats. Once treated, the rats ...

HIMS stock up 16% on Wednesday, continuing month-long gains. Novo Nordisk ends partnership, cites misleading marketing and safety concerns.

Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from ...

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...